Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive reference ranges for cardiovascular magnetic resonance: time to move on from single centre data?

The international journal of cardiovascular imaging·2025
Same author

Re-exploration following caesarean birth: a prospective national case-control study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection system.

Anaesthesia·2024
Same author

Direct current cardioversion in pregnancy: a multicentre study.

BJOG : an international journal of obstetrics and gynaecology·2023
Same author

Prevalence of pre-eclampsia and adverse pregnancy outcomes in women with pre-existing cardiomyopathy: a multi-centre retrospective cohort study.

Scientific reports·2023
Same author

Role of ethnicity in high-level obstetric clinical incidents: a review of cases from a large UK NHS maternity unit.

BMJ open quality·2022
Same author

Perturbations in cardiac metabolism in a human model of acute myocardial ischaemia.

Metabolomics : Official journal of the Metabolomic Society·2021

Related Experiment Video

Updated: May 19, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Heart disease in pregnancy.

Sarah Vause1, Bernard Clarke

  • 1St. Mary's Hospital, Manchester, UK. sarah.vause@cmft.nhs.uk

British Journal of Hospital Medicine (London, England : 2005)
|August 10, 2012
PubMed
Summary

Pregnancy can worsen heart conditions in women, making heart disease the leading cause of maternal death. Multidisciplinary care is crucial for managing pregnant women with cardiac disease.

Area of Science:

  • Cardiology
  • Maternal Health
  • Obstetrics

Background:

  • Cardiac disease presents significant risks during pregnancy due to physiological cardiovascular changes.
  • Heart disease is identified as the primary cause of mortality in pregnant women.
  • Effective management necessitates a coordinated, multidisciplinary approach.

Purpose of the Study:

  • To highlight the risks of cardiac disease in pregnancy.
  • To emphasize the importance of multidisciplinary collaboration.

Main Methods:

  • Review of existing literature on pregnancy and cardiac disease.
  • Analysis of maternal mortality data related to heart conditions.
  • Case study examples illustrating multidisciplinary care.

More Related Videos

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography
08:01

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography

Published on: November 22, 2013

Related Experiment Videos

Last Updated: May 19, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography
08:01

In utero Measurement of Heart Rate in Mouse by Noninvasive M-mode Echocardiography

Published on: November 22, 2013

Main Results:

  • Physiological adaptations during pregnancy can lead to decompensation in women with pre-existing cardiac conditions.
  • High incidence of maternal mortality directly linked to heart disease.
  • Successful outcomes are associated with integrated care teams.

Conclusions:

  • Pregnant women with cardiac disease require specialized, multidisciplinary care.
  • Early identification and management of cardiac risks are vital for reducing maternal mortality.
  • Collaboration among cardiologists, obstetricians, and other specialists improves patient outcomes.